We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Apple, KLA-Tencor, Intel, Cree and Xilinx
Read MoreHide Full Article
For Immediate Release
Chicago, IL – April 12, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include:Apple (AAPL - Free Report) , KLA-Tencor Corp. (KLAC - Free Report) , Intel (INTC - Free Report) , Cree, Inc. and Xilinx, Inc. .
Here are highlights from Thursday’s Analyst Blog:
3 Semiconductor Stocks to Buy Right Now
Shares of some of the biggest names in the semiconductor industry have surged in 2019. The climb is due in part because Wall Street and investors began to see value in some chip names after many tumbled, along with other tech giants, to end 2018.
With that said, the historically cyclical semiconductor industry appears to be in the midst of a downturn. Companies in the industry are beholden to their customers’ product cycles, capital investments, and more. On top of that, chip oversupply can hurt pricing power, as is currently the case for some firms in the industry.
Still, despite the current woes, the industry looks poised to remain highly valuable within the larger technological revolution. Semiconductor companies are poised to help drive forward the growth of the Internet of Things, artificial intelligence, autonomous vehicles, and much more. And it won’t just be the likes of Apple that are set to turn big profits and see their stocks climb as these industries expand.
Therefore, a return to growth is likely on the horizon for the industry as a whole, even if some face rough near-term outlooks. So, let’s take a look at three Zacks buy-ranked semiconductor stocks right now.
1. KLA-Tencor Corp.
KLA-Tencor is part of the Semiconductor Equipment - Wafer Fabrication industry and is one of the largest semiconductor equipment companies in the world. The firm provides advanced process control solutions for manufacturing wafers and reticles, along with integrated circuits and packaging. Shares of KLAC have soared roughly 40% since the start of the year, hitting new highs along the way. The firm, which recently received Intel’s 2018 Preferred Quality Supplier award, currently pays a $0.75 per share dividend and has a yield of 2.54%.
KLA-Tencor is a Zacks Rank #2 (Buy) right now based on its positive earnings estimate revision activity. Looking ahead, the company is expected to see its current adjusted full-year EPS figure pop 5.4% on the back of 11.9% revenue growth. Peeking further down the road, KLAC’s earnings are projected to jump 11.3% above our current-year estimate in the following year on 17% revenue expansion. The company also rocks a “B” grade for Value in our Style Scores system and is trading in line with its industry’s average P/E at 14.63.
2. Cree, Inc.
Cree is a manufacturer of LEDs and semiconductors that enhance the value of solid-state lighting, power and communications products. The company’s “SmartCast” platform enables Power over Ethernet technology and is geared toward IoT products and Smart Building platforms. Cree rocks a Zacks Rank #2 (Buy) at the moment and shares have soared 51% in 2019, to blow away the S&P 500 and the broader industry.
The Durham, North Carolina-based company has a strong history of quarterly earnings beats. This includes an average earnings surprise of 52% in the trailing four periods. Plus, analysts expect Cree’s current fiscal year earnings, which ends in June, to skyrocket 310%. Better yet, this growth is expected to continue to the tune of another 63% in the following year. The company also sports an “A” Grade for Growth in our Style Scores system.
3. Xilinx, Inc.
Xilinx’s Adaptive Compute Acceleration Platform is situated to help support the expansion of everything from AI and machine vision to databases and data compression. The company’s stock price has soared 55% in 2019 to help XLNX hit new highs along the way. Meanwhile, Xilinx’s position in the Semiconductors – Programmable Logic industry, which currently ranks #2 out of the 256 industries in our Zacks system, could help XLNX’s climb continue.
Xilinx posted record Q3 revenue and declared a quarterly cash dividend of $0.36 a share. Looking ahead, the company is projected to see its fiscal Q4 revenues surge roughly 23% from the year-ago quarter, based on our current Zacks Consensus Estimate. At the bottom end of the income statement, Xilinx’s adjusted Q4 earnings are expected to soar 48.5%. Xilinx is currently a Zacks Rank #2 (Buy) and is scheduled to release its fourth-quarter financial results on April 24.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Apple, KLA-Tencor, Intel, Cree and Xilinx
For Immediate Release
Chicago, IL – April 12, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include:Apple (AAPL - Free Report) , KLA-Tencor Corp. (KLAC - Free Report) , Intel (INTC - Free Report) , Cree, Inc. and Xilinx, Inc. .
Here are highlights from Thursday’s Analyst Blog:
3 Semiconductor Stocks to Buy Right Now
Shares of some of the biggest names in the semiconductor industry have surged in 2019. The climb is due in part because Wall Street and investors began to see value in some chip names after many tumbled, along with other tech giants, to end 2018.
With that said, the historically cyclical semiconductor industry appears to be in the midst of a downturn. Companies in the industry are beholden to their customers’ product cycles, capital investments, and more. On top of that, chip oversupply can hurt pricing power, as is currently the case for some firms in the industry.
Still, despite the current woes, the industry looks poised to remain highly valuable within the larger technological revolution. Semiconductor companies are poised to help drive forward the growth of the Internet of Things, artificial intelligence, autonomous vehicles, and much more. And it won’t just be the likes of Apple that are set to turn big profits and see their stocks climb as these industries expand.
Therefore, a return to growth is likely on the horizon for the industry as a whole, even if some face rough near-term outlooks. So, let’s take a look at three Zacks buy-ranked semiconductor stocks right now.
1. KLA-Tencor Corp.
KLA-Tencor is part of the Semiconductor Equipment - Wafer Fabrication industry and is one of the largest semiconductor equipment companies in the world. The firm provides advanced process control solutions for manufacturing wafers and reticles, along with integrated circuits and packaging. Shares of KLAC have soared roughly 40% since the start of the year, hitting new highs along the way. The firm, which recently received Intel’s 2018 Preferred Quality Supplier award, currently pays a $0.75 per share dividend and has a yield of 2.54%.
KLA-Tencor is a Zacks Rank #2 (Buy) right now based on its positive earnings estimate revision activity. Looking ahead, the company is expected to see its current adjusted full-year EPS figure pop 5.4% on the back of 11.9% revenue growth. Peeking further down the road, KLAC’s earnings are projected to jump 11.3% above our current-year estimate in the following year on 17% revenue expansion. The company also rocks a “B” grade for Value in our Style Scores system and is trading in line with its industry’s average P/E at 14.63.
2. Cree, Inc.
Cree is a manufacturer of LEDs and semiconductors that enhance the value of solid-state lighting, power and communications products. The company’s “SmartCast” platform enables Power over Ethernet technology and is geared toward IoT products and Smart Building platforms. Cree rocks a Zacks Rank #2 (Buy) at the moment and shares have soared 51% in 2019, to blow away the S&P 500 and the broader industry.
The Durham, North Carolina-based company has a strong history of quarterly earnings beats. This includes an average earnings surprise of 52% in the trailing four periods. Plus, analysts expect Cree’s current fiscal year earnings, which ends in June, to skyrocket 310%. Better yet, this growth is expected to continue to the tune of another 63% in the following year. The company also sports an “A” Grade for Growth in our Style Scores system.
3. Xilinx, Inc.
Xilinx’s Adaptive Compute Acceleration Platform is situated to help support the expansion of everything from AI and machine vision to databases and data compression. The company’s stock price has soared 55% in 2019 to help XLNX hit new highs along the way. Meanwhile, Xilinx’s position in the Semiconductors – Programmable Logic industry, which currently ranks #2 out of the 256 industries in our Zacks system, could help XLNX’s climb continue.
Xilinx posted record Q3 revenue and declared a quarterly cash dividend of $0.36 a share. Looking ahead, the company is projected to see its fiscal Q4 revenues surge roughly 23% from the year-ago quarter, based on our current Zacks Consensus Estimate. At the bottom end of the income statement, Xilinx’s adjusted Q4 earnings are expected to soar 48.5%. Xilinx is currently a Zacks Rank #2 (Buy) and is scheduled to release its fourth-quarter financial results on April 24.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.